Hony offloads 11% stake in CSPC

The private equity firm raises HK$4.095 billion from the sale of 650 million secondary shares in the Chinese pharmaceuticals group.
August 29, 2014

Private equity firm Hony Capital divested an 11% stake in CSPC Pharmaceutical after Thursday's close in Hong Kong, raising HK$4.095 billion (US$528 million) from the sale of 650 million secondary shares.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Related Articles

Hony Capital trims CSPC Pharma stake

Private equity firm Hony Capital raised $484 million after selling 10% of its shares in CSPC Pharma in an accelerated block in Hong Kong.
May 27, 2014